“As COVID-19 vaccine development has moved forward at an unprecedented pace, though, some pharmaceutical companies have started human trials before monkey studies have concluded. And with monkeys so hard to come by, others are wondering if certain studies can be skipped altogether.” The Atlantic: America Is Running Low on a Crucial Resource for COVID-19 Vaccines: The country is facing a monkey shortage. (We could always just use less evolved humans…)